Addus HomeCare (NASDAQ:ADUS – Free Report) had its target price reduced by Stephens from $110.00 to $105.00 in a research report sent to investors on Wednesday morning, Benzinga reports. Stephens currently has an overweight rating on the stock. A number of other research firms have also commented on ADUS. Raymond James boosted their price target […]